Skip to content
healthcare.dev

RETROVIR

NDC 49702-213, zidovudine, injection, solution, from ViiV Healthcare Company.

Product NDC
49702-213
Status
Listed
Labeler
ViiV Healthcare Company
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA019951
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49702-213 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ZIDOVUDINE10 mg/mL

Pharmacologic classes

Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
49702-213-26497020213265 VIAL, SINGLE-USE in 1 CARTON (49702-213-26) / 20 mL in 1 VIAL, SINGLE-USE (49702-213-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6df09f15-b102-431c-adde-d7aeef6f5d84
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=49702-213

Use it

Look up 49702-213 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49702-213 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49702-213. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.